Core Viewpoint - The announcement by Haocen Medical indicates a significant change in the company's control structure due to the termination of a cooperation agreement between its major shareholder and another investment firm, which will not adversely affect the company's normal operations [1] Summary by Relevant Sections - Change in Control The cooperation agreement between Guangzhou Huiyin Rifen Investment Partnership and Beijing Shoutuo Ronghui Investment has been terminated, resulting in a change of control over Haocen Medical. The voting rights corresponding to the 23.81% shares held by Huiyin Rifen will now be controlled by Huiyin Aofeng instead of Beijing Shoutuo Ronghui [1] - Shareholding Structure Huiyin Aofeng has a balanced shareholding structure among its shareholders without a controlling party, meaning that the company currently has no actual controller following this change [1] - Impact on Operations The change in control is stated to have no negative impact on the normal production and operation of the company, ensuring stability despite the shift in governance [1]
皓宸医疗:实控人由解直锟变更为无实控人